Atorvastatin in the Treatment of Mandibular Degree II Furcation Defects
Clinical Efficacy of Subgingivally Delivered Atorvastatin in the Treatment of Mandibular Degree II Furcation Defects: A Randomized Controlled Clinical Trial .
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
ABSTARCT Background: Atorvastatin is an inhibitor of 3-hydroxy-2-methyl-glutaryl coenzyme A reductase. Lately, it has shown to have anti-inflammatory and bone stimulatory effects. The aim of the current study is to explore the effectiveness of 1.2% atorvastatin (ATV) as an adjunct to scaling and root planning (SRP) in the treatment of mandibular degree II furcation defects. Method: A total of sixty subjects were randomly assigned to two treatment groups. 1. SRP plus placebo gel 2. SRP plus 1.2% ATV gel. Clinical parameters like probing depth (PD), relative vertical clinical attachment level (RVCAL) , relative horizontal clinical attachment level (RHCAL), modified sulcus bleeding index (mSBI) and site specific plaque index were recorded at baseline and then at 3, 6 and 9 months. The radiological assessment of bone defect fill was done at 6 and 9 months, using a computer-aided software.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Nov 2013
Shorter than P25 for phase_2
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2014
CompletedFirst Submitted
Initial submission to the registry
November 30, 2014
CompletedFirst Posted
Study publicly available on registry
March 11, 2015
CompletedMarch 11, 2015
November 1, 2014
8 months
November 30, 2014
March 5, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
amount of bone fill
baseline to 9 months
Secondary Outcomes (5)
change in Relative vertical clinical attachment level
baseline to 9 months
change in RHCAL (relative horizontal clinical attachment level)
baseline to 9 months
change in probing depth
baseline to 9 months
change in site specific plaque index
baseline to 9 months
change in modified sulcus bleeding index
baseline to 9 months
Study Arms (2)
SRP plus placebo
PLACEBO COMPARATORSRP was done for all the subjects. Placebo gel was delivered subgingivally into the pocket
SRP plus Atorvastatin
ACTIVE COMPARATORSRP was done for all the subjects. Atorvastatin was delivered in the pocket subgingivally
Interventions
After SRP, ATV gel was delivered subgingivally into the pocket
Eligibility Criteria
You may qualify if:
- lower first molars demonstrating a probing pocket depth of 5 mm and horizontal probing depth of 3 mm following phase 1 therapy, with furcation defects (degree II) present bucally in asymptomatic, vital lower first molars, with a furcation radiolucency on a periapical radiograph of the molars.
You may not qualify if:
- patients with systemic diseases like cardiovascular disease
- diabetes or HIV infection or on medications like corticosteroids which may impede the healing in periodontal tissues.
- pregnant/lactating females
- tobacco users
- alcoholics
- patients with unsatisfactory oral hygiene (plaque index greater than 1.5)
- teeth having gingival recession, caries involving pulp, intrabony defect present interproximally, grade 2/3 mobility
- Furthermore, patients allergic to ATV or other statins or those taking ATV/other statins systemically were excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor and head, department of periodontics
Study Record Dates
First Submitted
November 30, 2014
First Posted
March 11, 2015
Study Start
November 1, 2013
Primary Completion
July 1, 2014
Study Completion
July 1, 2014
Last Updated
March 11, 2015
Record last verified: 2014-11